82412-17-7 Usage
General Description
(7-methoxy-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid is a chemical compound with the molecular formula C12H10O5. It is a derivative of 4-methylumbelliferone, a coumarin compound commonly found in plants. (7-methoxy-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid is a potential drug candidate for the treatment of various diseases due to its anti-inflammatory and antioxidant properties. It has also shown potential as an anti-cancer agent, particularly in the inhibition of cancer cell migration and invasion. Additionally, (7-methoxy-4-methyl-2-oxo-2H-chromen-3-yl)acetic acid has been investigated for its potential use in the treatment of diabetes and neurodegenerative diseases. The compound is primarily used in scientific research and has not been approved for medical use in humans.
Check Digit Verification of cas no
The CAS Registry Mumber 82412-17-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,4,1 and 2 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 82412-17:
(7*8)+(6*2)+(5*4)+(4*1)+(3*2)+(2*1)+(1*7)=107
107 % 10 = 7
So 82412-17-7 is a valid CAS Registry Number.
82412-17-7Relevant articles and documents
Novel photochromic 3-(3-coumarinyl)-4-(3-thienyl)maleic acid cyclic derivatives
Traven, Valery F.,Bochkov, Andrei Yu.,Krayushkin, Mikhail M.,Yarovenko, Vladimir N.,Barachevsky, Valery A.,Beletskaya, Irina P.
, p. 22 - 24 (2010)
Novel unsymmetrical photosensitive derivatives of maleic acid, anhydride and N-alkylimide, including coumarin and thiophene moieties, have been designed and synthesized; their photochromism study and fatigue resistance estimation are reported.
Modified coumarins. 25. N-acyl cytisine derivatives containing a coumarin fragment
Nagorichna,Ogorodniichuk,Garazd,Vinogradova,Khilya
, p. 10 - 14 (2008/02/12)
New modified cytisine derivatives were prepared by acylation with coumarin-3-acetic acids. Springer Science+Business Media, Inc. 2007.